UTI Healthcare Fund - Regular Plan - IDCW

UTI Healthcare Fund - Regular Plan - IDCW - Portfolio Analysis

Portfolio Overview

As of September 30, 2025

Asset Allocation

Equity: 98.98%Others: 1.02%

Market Cap

Large Cap: 22.40%Mid Cap: 33.54%Small Cap: 40.04%Equity: 2.99%

Number of stocks

41

Top 10 Holdings

95.00% of portfolio

Market Cap of Equity

Large Cap
22.4047%
Mid Cap
33.5409%
Small Cap
40.0444%
Equity
2.9852%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd19.21%
Ajanta Pharma Ltd10.97%
Cipla Ltd10.96%
Lupin Ltd9.41%
Procter & Gamble Health Ltd7.97%
Glenmark Pharmaceuticals Ltd7.48%
Dr Reddy's Laboratories Ltd7.47%
Gland Pharma Ltd7.24%
Apollo Hospitals Enterprise Ltd7.16%
Alkem Laboratories Ltd7.12%

Sector Allocation of Equity

Healthcare97.90%
Basic Materials1.07%

SIP Amount

Monthly SIP Date

UTI Healthcare Fund - Regular Plan - IDCW

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.